|
Dabur Pharma Ltd. The principal activities of the Group are manufacturing and marketing of oral and injectable dosage forms and active pharmaceutical ingredients and intermediates. The Group also works in the field of cancer research and anticancer products. It markets products in the cardiovascular, antibacterial, antidiabetic & digestive segments. The Group markets its products in India, Nepal, Bangladesh, Sri Lanka, Thailand, Philippines, Malaysia, Vietnam, Myanmar, Jordan, Cyprus, Russia, Ukraine, Belarus, Georgia, Hungary, - Kenya, Nigeria, Ghana, Zimbabwe, Brazil, Colombia, Venezuela, Peru, Costa Rica, Mexico, Barbados and Jamaica. Dabur Pharma Limited is the leading Indian company for cancer research and anticancer products. The company also markets a range of products in the cardiovascular, antibacterial, antidiabetic & digestive segments. Dabur Pharma Limited, a public limited company incorporated in March 2003, is an associate company of Dabur India Limited, a US $ 250 million healthcare company founded in 1884. Dabur Pharma Limited operates in Europe and in some other markets through its fully owned subsidiary - Dabur Oncology Plc. The Dabur group of companies have a legacy of trust and excellence in the healthcare business.
|
